|
Epitope |
Antibody |
|
|
A
B
C
D
E
F
G
H
K
M P
S
T
V |
|
ALK |
mAb ALK1 |
Herlev, DK
(Run 17)
■
Sundsvall,
SE (Run 17) |
|
mAb 5A4 |
Jyväskylä,
FI (Run 17) |
|
AMACR |
mAb 13H4 |
Sønderborg,
DK (Run 16)
■
Umeå, SE
(Run 16) |
|
pAb ab12498 |
St.-Petersburg,
RU (Run 16) |
|
mAb CP200C |
Rovaniemi, FI
(Run 16) |
|
ASMA |
mAb 1A4 |
Hillerød,
DK (Run 21)
■
St.-Petersburg,
RU (Run 21) |
|
Bcl-2 |
mAb 100 |
Sønderborg, DK
(Run 13) |
|
mAb 124 |
Skövde, SE
(Run 13) |
|
mAb 8C8 |
Jyväskylä, FI
(Run 13) |
|
mAb bcl-2/100/D5 |
Stavanger, NO
(Run 13) |
|
Bcl-6 |
mAb GI191E/A8 |
Anonymous
(Run 17) |
|
mAb PG-B6p |
Norbyhagen,
NO (Run 17)
■
Seinäjoki,
FI (Run 17) |
|
Calretinin
(CR) |
mAb 5A5 |
Rotterdam, NL
(Run 23)
■
Tønsberg, NO
(Run 23) |
|
mAb Dak-Calret1 |
Anonymous
(Run 23)
■
Mistelbach,
AT (Run 23) |
|
pAb 18-0211 |
Stockholm, SE
■
Wien, AT
(Run 23) |
|
Carcinoembryonic antigen |
mAb II-7 |
Oslo, NO (Run
12)
■
Sundsvall, SE (Run
12) |
|
mAb Col-1 |
Odense, DK (Run
12) |
|
CA125 |
mAb M11 |
Lund, SE
(Run 15) |
|
mAb Ov185:1 |
Drammen, NO
(Run 15) |
|
mAb OC125 |
Malmö, SE
(Run 15) |
|
CD3 |
mAb 2GV6 |
Malmö, SE
(Run 22) |
|
mAb F7.2.38 |
Sarajevo, BA
(Run 22) |
|
mAb LN10 |
Rotterdam, NL (Run 22) |
|
mAb PS1 |
Oulu, FI
(Run 22) |
|
mAb SP7 |
Skive, DK
(Run 22) |
|
pAb A0452 |
Bodø, NO
(Run 22) |
|
CD4 |
mAb 1F6 |
Luleå, SE
(Run 14)
■
Bergen, NO
(Run 14) |
|
mAb 4B12 |
Odense, DK
(Run 14)
■
Trondheim, NO
(Run 14) |
|
CD5 |
mAb 4C7 |
Aliso Viejo,
USA (Run 17)
■
Lahti, FI
(Run 17) |
|
rmAb SP19 |
Anonymous
(Run 17)
■
Rotterdam,
NL (Run 17) |
|
CD8 |
mAb 1A5 |
Irvine, USA
(Run 14) |
|
mAb 4B11 |
Seinäjoki, FI
(Run 14) |
|
mAb CD8/144B |
Västerås, SE
(Run 14) |
|
CD10 |
mAb 56C6 |
Helsinki, FI
(Run 16)
■
ME 's-Hertogenbosch,
NL (Run16)
■
Oslo, NO
(Run 16) |
|
CD14 |
mAb 7 |
Helsinki, FI (Run
11)
■
Næstved, DK (Run
11) |
|
CD15 |
mAb C3D-1 |
Rijeka, HR
(Run 22) |
|
mAb Carb-3 |
Gentofte, DK
(Run 22) |
|
mAb MMA |
Firenze, IT
(Run 22)
■
Vienna, AT
(Run 22) |
|
CD20 |
mAb L26 |
Granada, ES (Run
21)
■
Lahti, FI
(Run 21)
■
Oslo, NO (Run
21) |
|
pAb RN-9013 |
Ålesund, NO (Run
21) |
|
CD23 |
mAb 1B12 |
Randers, DK (Run 19)
■
Roskilde, DK
(Run 19)
■
Uppsala, SE (Run 19) |
|
rmAb SP23 |
Trondheim, NO (Run 19) |
|
CD30 |
mAb Ber-H2 |
Borås, SE (Run
11)
■
Firenze, IT
(Run 11)
■
Jönköping, SE
(Run 11)
■
Odense, DK (Run
11)
■
Trondheim, NO
(Run 11) |
|
CD31 |
mAb JC/70A |
Odense, DK (Run 11)
■
Skien, NO (Run 11)
■
Sundsvall, SE (Run 11)
■
Århus, DK (Run 11) |
|
CD34 |
mAb My10 |
RH, København, DK (Run 7) |
|
mAb QBEnd 10 |
Glostrup, DK (Run
7)
■
Kristiansand, NO (Run
7)
■
Næstved, DK (Run
7)
|
|
CD45 |
mAb 2B11+PD7/26 |
Trondheim, NO
(Run 15)
■
Sundsvall, SE
(Run 15) |
|
mAb RP2-18 |
Irvine, USA
(Run 15) |
|
mAb T29/33 |
Guangzhou, CHN
(Run 15) |
|
CD68 |
mAb KP1 |
Oslo, NO (Run
11)
■
Växjö, SE (Run
11) |
|
mAb PG-M1 |
Helsingborg, SE
(Run 11)
■
Stockholm, SE
(Run 11) |
|
CD79a |
mAb JCB117 |
Haag, NL
(Run 21)
■
Roskilde,
DK (Run 21)
■
Stavanger,
NO (Run 21) |
|
rmAb SP18 |
Bonn, DE (Run
21)
■
Jyväskylä,
FI (Run 21) |
|
CD99 |
mAb 12E7 |
Aalborg, DK (Run 12)
■
Karlstad, SE (Run
12) |
|
CD117 |
pAb A4502 |
Næstved,
DK
(Run 21)
■
Rotterdam,
NL (Run 21)
■
Sundsval,
SE (Run 21)
■
Vilnius,
LT (Run 21) |
|
CD138 |
mAb B-A38 |
Castelfranco Veneto, IT (Run 21)
■
Kristiansand,
NO (Run 21) |
|
mAb B-B4 |
Seinajoki,
FI (Run 21) |
|
mAb BC/B-B4 |
Saskatoon,
CA (Run 21) |
|
mAb MI15 |
Linköping,
SE (Run 21) |
|
CDX2 |
mAb AMT-28 |
Stockholm, SE
(Run 22) |
|
mAb CDX2-88 |
Helsinki, FI
(Run 22) |
|
Chromogranin
(CGA) |
mAb LK2H10 |
Treviglio, IT
(Run 22)
■
Uppsala, SE
(Run 22) |
|
|
mAb LK2H10+PHE5 |
Halmstad, SE
(Run 22) |
|
|
pAb A0430 |
Gävle, SE
(Run 22)
■
Skien, NO
(Run 22) |
|
Cyclin D1 |
rmAb SP4 |
Drammen, NO (Run 19)
■
Rotterdam, NL
(Run 19) |
|
mAb P2D11F11 |
Seinäjoki, FI
(Run 19) |
|
Cytokeratin,
high molecular weight |
mAb 34BE12 |
Malmö, SE
(Run 16)
■
Skien, NO
(Run 16)
■
Triviglio,
IT (Run 16) |
|
mAb D5/16 B4 |
Odense, DK
(Run 16) |
|
mAb XM26 |
Karlstad, SE
(Run 16) |
|
Cytokeratin,
low molecular weight |
mAb 5D3 |
Rotterdam, NL
(Run 20) |
|
mAb C51 |
Hjørring, DK (Run
20) |
|
mAb CAM 5.2 |
Edmonton, CA (Run
20) |
|
mAb DC10 |
Reykjavik, IS
(Run 20)
■
Treviglio, IT
(Run 20) |
|
Cytokeratin 5 |
mAb 34BE12 |
Irvine, USA (Run
12)
■ Luleå, SE
(Run 12) |
|
mAb D5/16 B4 |
Seinäjoki, FI
(Run 12)
■
Svendborg, DK
(Run 12) |
|
mAb XM26 |
Kalmar, SE
(Run 12)
■
Stockholm, SE
(Run 12) |
|
Cytokeratin 7 |
mAb K72 |
Anonymous (Run
8) |
|
mAb K72.7 |
Jyväskylä, FI (Run
8) |
|
mAb
OV/TL 12/30 |
Borås, SE
(Run 8)
■
Oslo, NO (Run 8) |
|
Cytokeratin 20 |
mAb
Ks 20.8 |
Molde, NO (Run 8)
■
Seinäjoki, FI (Run 8)
■
Växjö, SE (Run 8) |
|
Cytokeratin, pan- |
mAb AE1/AE3 |
Bodø, NO
(Run 20)
■
Karlskrona, SE
(Run 20) |
|
mAb AE1/AE3+5D3 |
Esbjerg, DK
(Run 20) |
|
mAb KL1 |
Bispebjerg,
København, DK (Run 20) |
|
mAb MNF116 |
Trollhättan, SE
(Run 20) |
|
mAb Pan CK, Ab2 |
Ålesund, NO
(Run 20) |
|
Desmin |
mAb D33 |
Helsingborg,
SE (Run 21)
■
Wien, AT (Run
21) |
|
mAb DE-R-11 |
Aliso Viejo,
USA (Run 21)
■
Uppsala, SE (Run
21) |
|
mAb ZN-18 |
Hämeenlinna,
FI (Run 21) |
|
E-cadherin (ECAD) |
mAb 36B5 |
Mistelbach,
AT (Run B5) |
|
mAb ECH-6 |
Århus, DK
(Run B5) |
|
mAb HECD-1 |
Göteborg,
SE (Run B5) |
|
mAb NCH-38 |
Haarlem, NL
(Run B5) |
|
EMA |
mAb
E29 |
Falun, SE (Run
10)
■
Holstebro, DK (Run 10)
■
Næstved, DK (Run
10)
■ Tampere, FI (Run
10) |
|
Epithelial antigen (Ep-CAM) |
mAb Ber-EP4 |
Norbyhagen,
NO (Run 23)
■
Stockholm, SE (Run 23) |
|
mAb MOC-31 |
Wien, AT
(Run 23) |
|
mAb VU-1D9 |
Apeldoorn,
NL (Run 23) |
|
Estrogen receptor |
mAb 1D5 |
Hjørring, DK
(Run B5) |
|
mAb 1D5+ER-2-123 |
Anonymous
(Run B5) |
|
mAb 6F11 |
Helsinki, FI
(Run B5)
■
Roskilde, DK
(Run B5) |
|
rmAb SP1 |
Roermond, NL
(Run B5)
■
Vejle, DK
(Run B5) |
|
Factor VIII related antigen
|
pAb 760-2642 |
Oslo, NO (Run
11) |
|
pAb A0082 |
Lindköping, SE
(Run 11)
■
Skövde, SE (Run
11)
■
Tampere, FI (Run
11) |
|
Glial fibrillary acidic protein |
mAb 6F2 |
Falun, SE
(Run 13)
■ Karlstad,
SE (Run 4) |
|
mAb GA5 |
Kaunas, LT
(Run 13) |
|
pAb Z0334 |
Anonymous
(Run 13)
■
Seinäjoki, FI (Run 13) |
|
HER-2 |
pAb A0485 |
Genk, BE
(Run B5) |
|
HercepTest |
Aliso Viejo, USA
(Run B5) |
|
Pathway |
Castelfranco Veneto,
IT (Run B5) |
|
Human chorionic
gonadotropin |
pAb A231 |
Esbjerg, DK (Run11)
■
Holstebro, DK (Run
11)
■
Lund, SE (Run
11) |
|
pAb NCL-HCGp |
Firenze, IT (Run
11) |
|
IgK |
pAb A0191 |
Jönköping,
SE (Run 23)
■
Odense, DK
(Run 23) |
|
IgL |
pAb A0193 |
Stockholm, SE
(Run 15)
■
Holstebro, DK
(Run 15) |
|
IgM |
pAb A0425 |
Bergen, NO
(Run 23)
■
Seinäjoki,
FI (Run 23)
■
Wien,
AT (Run 23) |
|
Ki67 |
mAb K2 |
's-Hertogenbosch,
NL (Run 19) |
|
mAb MIB1 |
Esbjerg, DK
(Run 19)
■
Trondheim, NO
(Run 19)
■
Århus, DK
(Run 19) |
|
mAb MM1 |
Kiev, UA
(Run 19) |
|
rmAb 30-9 |
Tønsberg, NO
(Run 19) |
|
rmAb SP6 |
Linz, AT
(Run 19)
■
Ålesund, NO
(Run 19) |
|
MLA |
mAb A103 |
Danderyd, Stockholm, SE
(Run 20)
■
Dresden, DE
(Run 20)
■
Wien, AT
(Run 20) |
|
mAb
A103+M2+7C10+M2-9E3 |
Helsinki, FI
(Run 20) |
|
Mismatch repair proteins
MLH1 |
mAb G168-15 |
Hillerød, DK (Run
13)
■
Irvine, USA (Run
13)
■
Odense,
DK (Run 13)
■
Trondheim, NO (Run
13) |
|
Mismatch repair proteins
MSH2 |
mAb 25D12 |
Trondheim, NO
(Run 22) |
|
mAb 27 |
Roskilde, DK
(Run 22) |
|
mAb FE11 |
Næstved, DK
(Run 22) |
|
MSA-HMB45 |
mAb HMB45
(HIER) |
Firenze, IT
(Run 20)
■
Lillehammer, NO
(Run 20) |
|
mAb HMB45
(None) |
Berlin, DE
(Run 20)
■
Wien, AT
(Run 20) |
|
NFP |
mAb 2F11 |
Jönköping,
SE
(Run 18)
■
Sundsvall,
SE
(Run 18) |
|
mAb NFP7, DA2, RmdO20.11 |
Firenze, IT
(Run 18)
■
Oslo, NO
(Run 18) |
|
p53 |
mAb BP53-12 |
Barcelona, ES
(Run 20) |
|
mAb DO-1 |
Kassel, DE
(Run 20) |
|
mAb DO-7 |
Örebro, SE
(Run 20)
■
Sundsvall, SE
(Run 20) |
|
mAb DO-7+BP53-12 |
Wien, AT
(Run 20) |
|
p63 |
mAb 4A4 |
Linköping, SE
(Run 16)
■
Stockholm, SE
(Run 16) |
|
mAb 4A4 + Y4A3 |
Blaricum, NL
(Run 16) |
|
mAb BC4A4 |
Aliso Viejo,
USA (Run 16) |
|
Placental alkaline
phosphatase |
mAb NB10 |
Firenze, IT
(Run 14) |
|
mAb PL8-F6 |
Sønderborg, DK
(Run 14)
■
Uppsala, SE
(Run 14) |
|
Podop |
mAb
D2-40 |
Leiden, NL (Run 19)
■
RH,
København, DK
(Run 19) |
|
PR |
mAb 16 |
Roskilde, DK
(Run B4) |
|
mAb PGR 636 |
Wien, AT
(Run B4) |
|
rmAb 1E2 |
Århus, DK
(Run B4) |
|
rmAb SP2 |
Wien, AT
(Run B4) |
|
Prostate-specific antigen |
mAb 35H9 |
Aalborg, DK (Run
12) |
|
mAb ER-PR8 |
Bodø, NO (Run
12) |
|
mAb ER-PR8+PA05 |
Jyväskylä, FI (Run
12)
|
|
pAb 760-2506 |
Tønsberg,
NO (Run 12) |
|
pAb A0562 |
Karlskrona, SE
(Run 12)
■
Slagelse, DK
(Run 12)
|
|
Prostatic acid
phosphatase |
mAb PASE/4LJ |
Kristiansand, NO
(Run 12)
■
Seinäjoki, FI (Run
12) |
|
pAb A0627 |
Helsingborg, SE
(Run 12)
■
Holstebro, DK
(Run 12) |
|
S-100 |
pAb Z0311 (Prot) |
Luleå, SE
(Run 20)
■
Västerås, SE
(Run 20) |
|
pAb Z0311 (HIER) |
Wien, AT
(Run 20)
■
Århus, DK
(Run 20) |
|
SYP |
mAb 27G12 |
Mikkelin, FI
(Run 22) |
|
mAb Snp88 |
Hillerød, DK
(Run 22) |
|
pAb 18-0130 |
Turku, FI
(Run 22) |
|
pAb A0010 |
Örebro, SE
(Run 22) |
|
TdT |
mAb SEN28 |
Bergen, NO
(Run 18)
■
Sundsvall,
SE
(Run 18) |
|
pAb A3524 |
Herlev, DK
(Run 18)
■
Umeå, SE
(Run 18) |
|
pAb 004 |
Leiden, NL
(Run 18) |
|
TTF1 |
mAb SPT24 |
Hämeenlinna,
FI (Run 23)
■
Helsingborg, SE
(Run 23)
■
Trondheim,
NO (Run 23) |
|
Vimentin |
mAb 3B4 |
Mikkeli, FI
(Run 12) |
|
mAb SP20 |
Ålesund, NO
(Run 12) |
|
mAb V9 |
Esbjerg, DK
(Run 12)
■
Luleå, SE
(Run 12)
|
|
WT1 |
mAb 6F-H2 |
Vejle, DK
(Run 15)
■
Helsinki, FI
(Run 15) |
|